Pharma M&A deal value fell by more than 92% year-on-year

According to data compiled by ComprarAcciones , M&A deal activity in the pharma sector rose by 17% during the first half of 2020. To many, this would appear to be a positive shift, given the economic impacts of the pandemic. However, the rise in pharma industry deals might not […]

Click here to view original web page at ukinvestormagazine.co.uk